Boxer Capital Amends Tyra Biosciences Stake Filing
Ticker: TYRA · Form: SC 13D/A · Filed: Dec 6, 2024 · CIK: 1863127
| Field | Detail |
|---|---|
| Company | Tyra Biosciences, Inc. (TYRA) |
| Form Type | SC 13D/A |
| Filed Date | Dec 6, 2024 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 13D-filing, shareholder-activity, amendment
Related Tickers: TYRA
TL;DR
Boxer Capital updated their 13D filing for Tyra Biosciences, Inc. - watch for changes.
AI Summary
Boxer Capital Management, LLC, along with Aaron I. Davis and MVA Investors, LLC, filed an amendment (No. 6) to their Schedule 13D on December 6, 2024, regarding their holdings in Tyra Biosciences, Inc. The filing indicates a change in the group's beneficial ownership of the company's common stock.
Why It Matters
This amendment signals a potential shift in significant shareholder activity or strategy concerning Tyra Biosciences, which could influence stock price and corporate governance.
Risk Assessment
Risk Level: medium — Amendments to Schedule 13D filings often indicate changes in significant investor positions, which can lead to increased volatility.
Key Players & Entities
- Boxer Capital Management, LLC (company) — Filing entity
- Aaron I. Davis (person) — Group member
- MVA Investors, LLC (company) — Group member
- Tyra Biosciences, Inc. (company) — Subject company
- Josh La Grange (person) — Authorized to receive notices
FAQ
What specific changes were made in Amendment No. 6 to the Schedule 13D filing?
The filing is an amendment (No. 6) to the Schedule 13D, indicating changes in the information previously reported by the group concerning their beneficial ownership of Tyra Biosciences, Inc. The exact nature of the changes requires a deeper review of the amendment's content.
Who are the members of the group filing this Schedule 13D amendment?
The group members are identified as Boxer Capital Management, LLC, Aaron I. Davis, and MVA Investors, LLC.
What is the subject company of this filing?
The subject company is Tyra Biosciences, Inc.
When was this amendment filed with the SEC?
This amendment was filed on December 6, 2024.
What is the CUSIP number for Tyra Biosciences, Inc. common stock?
The CUSIP number for Tyra Biosciences, Inc. common stock is 90240B106.
Filing Stats: 1,515 words · 6 min read · ~5 pages · Grade level 11.9 · Accepted 2024-12-06 21:30:49
Key Financial Figures
- $0.0001 — , Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of
Filing Documents
- ff4209876_13da6-tyra.htm (SC 13D/A) — 111KB
- 0000895345-24-000607.txt ( ) — 113KB
is hereby amended by the addition of the following
Item 4 is hereby amended by the addition of the following: On December 4, 2024, BCM delivered to the Company a notification on behalf of a fund it manages that such fund had elected, pursuant to Section 11 of the Pre-Funded Warrants (which otherwise entitle the holder to purchase an aggregate of 2,000,237 shares of Common Stock), to decrease the Conversion Limit from 9.99% to 4.99% for each of the Pre-Funded Warrants. Item 5. Interest in Securities of the Issuer. Items 5(a) and (b) are hereby amended and restated to read as follows: (a) (b) For information regarding beneficial ownership, see the information presented on the cover pages.
(c) is hereby amended by the addition of the following
Item 5(c) is hereby amended by the addition of the following: (c) The disclosure set forth above in Item 4 above is hereby incorporated herein.
(e) is hereby amended by the addition of the following
Item 5(e) is hereby amended by the addition of the following: (e) As of December 4, 2024, the Reporting Persons ceased to beneficially own more than 5% of the outstanding shares of Common Stock.
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: December 6, 2024. AARON I. DAVIS /s/ Aaron I. Davis Aaron I. Davis, Individually MVA INVESTORS, LLC By: /s/ Aaron I. Davis Name: Aaron I. Davis Title: Authorized Signatory BOXER CAPITAL MANAGEMENT, LLC By: /s/ Aaron I. Davis Name: Aaron I. Davis Title: Managing Member